Spark Investment Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,510
Closed -$170K 380
2019
Q4
$170K Buy
10,510
+2,684
+34% +$63.5K 0.02% 471
2019
Q3
$273K Sell
7,826
-30,570
-80% -$1.45M 0.03% 299
2019
Q2
$2.17M Buy
+38,396
New +$2.76M 0.15% 188
2018
Q2
Sell
-20,076
Closed -$2.09M 655
2018
Q1
$2.09M Sell
20,076
-15,424
-43% -$1.74M 0.13% 214
2017
Q4
$3.58M Sell
35,500
-85,900
-71% -$6.32M 0.19% 169
2017
Q3
$4.24M Buy
121,400
+47,300
+64% +$1.28M 0.23% 155
2017
Q2
$1.77M Buy
74,100
+39,400
+114% +$990K 0.11% 269
2017
Q1
$962K Buy
+34,700
New +$808K 0.06% 422

Other funds holding ANAB

Spark Investment Management's ANAB Position: Q1 2020 in Review

Spark Investment Management sold out of AnaptysBio (ANAB) in Q1 2020, closing a stake of 10,510 shares — an estimated $170K sold.

Spark Investment Management first reported a position in ANAB in Q1 2017 and held it in 8 quarters. The position peaked at $4.24M in Q3 2017. 116 funds tracked by Wall St. Rank hold ANAB as of Q1 2020.

  • Spark Investment Management reported no remaining AnaptysBio position as of Q1 2020 after selling out during the quarter.
  • Spark Investment Management sold 10,510 AnaptysBio shares in Q1 2020, an estimated $170K.
  • Spark Investment Management first reported a position in AnaptysBio in Q1 2017 and held it in 8 quarters.
  • Spark Investment Management's AnaptysBio position peaked at $4.24M in Q3 2017.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.